Microarray analysis of blood microvessels from PDGF-B and PDGF-Rbeta mutant mice identifies novel markers for brain

Cecilia Bondjers1, Liqun He, Minoru Takemoto

  • 1Division of Matrix Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, SE 171 77, Stockholm, Sweden.

Insights

Researchers identified novel molecular markers for brain pericytes, crucial cells for microvessel development. This discovery aids in understanding microvascular diseases like diabetes and tumors.

Area of Science:

  • Neuroscience
  • Vascular Biology
  • Cell Biology

Background:

  • Pericytes are essential for microvessel development and stability, but their identification is challenging due to cellular heterogeneity and lack of specific markers.
  • Pericyte deficiency is linked to microvascular abnormalities in diseases such as diabetes and cancer.

Purpose of the Study:

  • To identify novel molecular markers for brain pericytes.
  • To understand the role of pericytes in microvessel development and stability.

Main Methods:

  • Transcription profiling of pericyte-deficient brain microvessels from PDGF-B-/- and PDGFRbeta-/- mouse mutants.
  • In situ hybridization to validate the expression of candidate markers.

Main Results:

  • Identified ATP-sensitive potassium-channel Kir6.1 (Kcnj8), sulfonylurea receptor 2 (SUR2, Abcc9), and delta homologue 1 (DLK1) as novel brain pericyte markers.
  • Demonstrated specific expression of these markers in embryonic mouse brain pericytes.
  • Showed Kir6.1 expression is specific to brain pericytes, unlike in skin or heart pericytes.

Conclusions:

  • Kir6.1, SUR2, and DLK1 are reliable markers for brain pericytes.
  • These markers are signaling molecules involved in ion and intercellular communication, offering new insights into brain pericyte function.

Related Concept Videos